Fundamental Analysis
33 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +9.3% | +10.3% | 3 / 3 | +10.0% | -16.58 pp | -0.10 pp | +13.1% | 0.54 | 8.67 | 192 | +10,0% | 32,6 | +9,3% | 8.67 | 10.79 | −19,6% |
| Pts | 0 | 0 | 12 | 0 | 0 | 4 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 14.400 (close price on 2026-10-19)EPS (TTM): 1.661
Financial charts
1.Revenue & growth
VND bn192Q2/26
1.Revenue & growth
VND bn192Q2/26
2.Profit & growth
VND bn32,2Q2/26
3.Profit mix (Penman)
VND bn165Q2/26
4.Margins & cost structure
%39.9%Q2/26
5.Returns & cash cycle
% · days11.8%Q2/26
6.Earnings quality & cash
VND bn312Q2/26
7.Asset structure
VND bn1.967Q2/26
8.Funding & debt health
VND bn · times1.967Q2/26
9.Revenue backlog
VND bn25,2Q2/26
10.Valuation
times · %8,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %368Q2/26
Adjusted EPS growth, latest quarter
8.0%
Average adjusted EPS growth, 3 quarters
9.9%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26